GLP3 also known by the brand name Reta is a triple hormone receptor agonist targeting GIP, GLP-1, and glucagon receptors. Designed for the treatment of obesity, type 2 diabetes, and metabolic disorders. It acts by simultaneously mimicking three gut hormones to regulate appetite, metabolism, and fat breakdown.
This item is listed in our catalogue using internal lot/SKU codes or the chemical formula instead of more common Brand names. You will receive the verified compound, properly labeled with full identification. If you’d like, contact us for more information.
Premium research-grade, supplied as a lyophilized compound for laboratory research use by qualified professionals. For laboratory research use only. Not for human or animal use.
Technical Specifications:
-
Purity: >99% (HPLC)
-
Molecular Formula: C221H342N46O68
-
Molecular Weight: 4731.33
-
Format: Lyophilized powder
Classification: Triple-receptor agonist (incretin-related).
Available concentrations: 5 mg and 10 mg
Research context: (LY3437943) is an investigational triple agonist targeting GIP, GLP-1, and glucagon receptors, widely studied for its effects on energy balance, body-weight regulation, and metabolic signaling. Current research interest includes incretin/glucagon pathway pharmacology, glycemic control mechanisms, and broader cardiometabolic endpoints observed in clinical research settings.
Handling & Storage
-
Storage Conditions: 2–8 °C, protected from light
-
Stability: Lyophilized format supports extended stability when stored under recommended conditions
-
Reconstitution: For laboratory research protocols only, using appropriate sterile laboratory techniques